Home › FDA Approves Merck's NOXAFIL (posaconazole) Injection (18 mg/mL) for Intravenous Use
 

Keywords :   


FDA Approves Merck's NOXAFIL (posaconazole) Injection (18 mg/mL) for Intravenous Use

2014-03-15 04:54:54| Biotech - Topix.net

Merck , known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved NOXAFIL injection , a new formulation of NOXAFIL for intravenous use.

Tags: use injection fda approves

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
09.11Atlantic Tropical Weather Outlook
09.11Eastern North Pacific Tropical Weather Outlook
08.11Hurricane Rafael Graphics
08.11Hurricane Rafael Wind Speed Probabilities Number 22
08.11Hurricane Rafael Forecast Advisory Number 22
08.11Hurricane Rafael Public Advisory Number 22
08.11Summary for Hurricane Rafael (AT3/AL182024)
08.11Trump tariffs could cost UK 22bn of exports
More »